News

This article covers USPTO’s new rules for discretionary denial of IPR and PGR petitions, focusing on factors like timing, ...
Jharkhand High Court held that review can only be sought if there is a mistake or an error apparent on the face of the record ...
Swissmedic has introduced a fast-track review process for clinical trial applications, aiming to speed up access to ...
RFK Jr. cancels U.S. Preventive Services Task Force meeting; the Department of Health and Human Services backtracked on its claim that it would release ethics forms for new members of the Advisory ...
Slayback Pharma, LLC, vacating an obviousness ruling by the Patent Trial and Appeal Board (PTAB) that invalidated Eye Therapies’ patent claims to methods of treating eye redness.
The Patent Trial and Appeal Board (PTAB) on Thursday designated as informative a Director Review decision in which Acting Director Coke Morgan Stewart said the Board abused its discretion by ...
As the medical device industry continues to expand, intellectual property (IP) considerations — especially those concerning ...
Desilva said ongoing litigation against Samsung and Micron in East Texas is moving in a positive direction for Netlist ...
Lexmark had decades-old roots in Lexington, was a major area employer and lead the printer industry with its innovating ...
This special feature contains summaries of “important opinions” published in Virginia Lawyers Weekly during the first half of ...
Psychedelics devotees are racing biotech entrepreneurs to turn 5-MeO-DMT, one of the world’s most powerful drugs, into a pharmaceutical.
The US Supreme Court ruled Friday that nationwide injunctions issued by lower-court judges “likely exceed” the judicial ...